Provided by Tiger Trade Technology Pte. Ltd.

Alterity Therapeutics Ltd

0.445
0.000
Volume:- -
Turnover:74.20K
Market Cap:96.79M
PE:-5.39
High:0.445
Open:0.445
Low:0.445
Close:0.445
52wk High:0.500
52wk Low:0.350
Shares:217.51M
Float Shares:217.51M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.083
EPS(LYR):-0.095
ROE:-47.02%
ROA:-32.54%
PB:1.78
PE(LYR):-4.69

Loading ...

Company Profile

Company Name:
Alterity Therapeutics Ltd
Exchange:
ASX
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Alterity Therapeutics Limited engages in the research and development of therapeutic drugs to treat Alzheimer's disease, Huntington disease, Parkinson's disease, and other neurological disorders in Australia. The company's lead drug candidate is ATH434 that has completed Phase I clinical trial for the treatment of Parkinson's disease. It is also developing PBT2 that has completed Phase 2a clinical trial to treat Alzheimer's disease. The company was formerly known as Prana Biotechnology Limited and changed its name to Alterity Therapeutics Limited in April 2019. Alterity Therapeutics Limited was incorporated in 1997 and is headquartered in Melbourne, Australia.